Mucuna pruriens seeds in treatment of Parkinson's disease: Pharmacological review

被引:23
|
作者
Kasture S. [1 ,2 ]
Mohan M. [3 ]
Kasture V. [1 ,2 ]
机构
[1] Sanjivani College of Pharmaceutical Education and Research, Dist. Ahmednagar, Kopargaon
[2] Pinnacle Biomedical Research Institute, Bhopal
[3] Priyadarshini College of Pharmaceutical Sciences, Narapally, Chowdaryguda, Hyderabad
来源
关键词
Antioxidants; Genistein; Mucuna pruriens; Neuroprotective; Unsaturated acids;
D O I
10.1007/s13596-013-0126-2
中图分类号
学科分类号
摘要
Medicinal plants have been a rich source of medicines. Mucuna pruriens is extensively used in Ayurveda to treat kampavat (Parkinson's disease in modern medicine), a disease characterized by excess of Vata. Clinical and preclinical studies have substantiated claims on its efficacy and safety in PD and there are indications that it is more effective than the levodopa in reducing dyskinesias. Several constituents of Mucuna seeds such as genistein, gallic acid, unsaturated acids, nicotine, bufotenin, harmin alkaloids, lecithin, etc. have been isolated which possess neuroprotective activity and support the antiPD activity of levodopa. The review describes various constituents of Mucuna pruriens seeds in context to therapeutic utility in treating Parkinson's disease. Since the conventional treatment of PD using levodopa with other add-on drugs is very expensive and Mucuna pruriens seeds are easily available and economic, the use of standardized extract of Mucuna seeds may drastically reduce the cost of treatment and also reduce the progression of disease. The review emphasizes the importance of holistic approach of Ayurveda in using the Mucuna pruriens in treatment of PD. Further studies may provide an approach to understand the mechanisms involved in treating PD with lesser adverse effects. © 2013 Institute of Korean Medicine, Kyung Hee University.
引用
收藏
页码:165 / 174
页数:9
相关论文
共 50 条
  • [1] Systematic review of Mucuna Pruriens as a treatment for Parkinson's disease
    Boonmongkol, T.
    Phokaewvarangkul, O.
    Vimolmangkang, S.
    Bhidayasiri, R.
    MOVEMENT DISORDERS, 2019, 34 : S30 - S32
  • [2] Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study
    Katzenschlager, R
    Evans, A
    Manson, A
    Patsalos, PN
    Ratnaraj, N
    Watt, H
    Timmermann, L
    Van der Giessen, R
    Lees, AJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (12): : 1672 - 1677
  • [3] Mucuna pruriens in Parkinson's disease: A double-blind clinical and pharmacological study
    Katzenschlager, R
    Evans, A
    Manson, A
    Patsalos, P
    Ratnaraj, N
    Lees, AJ
    MOVEMENT DISORDERS, 2004, 19 : S249 - S249
  • [5] Immunomodulation of Parkinson's disease using Mucuna pruriens (Mp)
    Rai, Sachchida Nand
    Birla, Hareram
    Zahra, Walia
    Sen Singh, Saumitra
    Singh, Surya Pratap
    JOURNAL OF CHEMICAL NEUROANATOMY, 2017, 85 : 27 - 35
  • [6] Potential therapeutic application of Mucuna pruriens for Parkinson's disease
    Sakata, M.
    Nishimori, H.
    Nomoto, M.
    Kondo, T.
    MOVEMENT DISORDERS, 2011, 26 : S260 - S260
  • [7] Mucuna pruriens: A new strategy for Parkinson's disease treatment in Africa. An update
    Cassani, E.
    Barichella, M.
    Cilia, R.
    Akpalu, A.
    Ofosu-Budu, K.
    Cham, M.
    Ferrario, E.
    Faceli, E.
    Zecca, L.
    Sparvoli, F.
    Privitera, G.
    De Marco, P.
    Zecchinelli, A.
    Bonetti, A.
    Iorio, L.
    Amboni, M.
    Cereda, E.
    Pezzoli, G.
    MOVEMENT DISORDERS, 2014, 29 : S136 - S137
  • [8] Beyond L-DOPA: Bioactives in Mucuna pruriens for the treatment of Parkinson's disease
    Hessler, Craig
    Niesen, Daniel
    Ma, Hang
    Seeram, Navindra
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [9] Mucuna Pruriens Combined with Carbidopa in Parkinson's Disease: A Case Report
    Radder, Danique L. M.
    Groenestege, Andreas T. Tiel
    Boers, Inge
    Muilwijk, Eline W.
    Bloem, Bastiaan R.
    JOURNAL OF PARKINSONS DISEASE, 2019, 9 (02) : 437 - 439
  • [10] Mucuna pruriens as adjunct therapy to levodopa in advanced Parkinson's disease
    Botello-Villagrana, Fernando
    Martinez-Ramirez, Daniel
    REVISTA MEXICANA DE NEUROCIENCIA, 2021, 22 (05): : 180 - 183